$32MSeries A, 25 September 2025
Oversubscribed Series A to run two randomized feasibility studies in HFpEF and HFrEF.
- Amount
- $32M
- Stage
- Series A
- Announced
- 25 September 2025
- Lead
- Earlybird Venture Capital
- Other investors
- Santé Ventures, Deerfield Management, CD Capital, KOFA Healthcare
- Use of funds
- Oversubscribed Series A to run two randomized feasibility studies in HFpEF and HFrEF.
- Checked
- Announced by the company
- Sources
- Axon Therapies secures $32M and more digital health funding - MobiHealthNews vcaonline.com
Axon Therapies secures $32M and more digital health funding - MobiHealthNews MobiHealthNews